Effect of Hyangsapyeongwisan on Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial

Korea Health Industry Development Institute0 个研究点目标入组 170 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•The inclusion criteria for this study were as follows;
•? All men and women aged between 20 and 70 years
•? All of the patients who meet the definition of the Rome ?
•? Patients with more than 2 moderate symptoms of epigastric pain, epigastric discomfort, epigastric burning, early satiety, postprandial fullness, epigastric pressure sense, epigastric bloating and nausea, and a total score or higher based on the following scale for each symptom:
•? 0 absence of the symptom.
•? 1 mild symptom: patients feel the symptoms during the medical examination of physicians but no treatment is required.
•? 2 moderate symptom: patients feel the symptoms but they seldom interfere with normal daily activities
•? 3 severe symptom: patients feel the symptoms interfere with normal daily activities

•Patients who report the following conditions will be excluded;
•? History of gastrointestinal surgery (except, appendectomy)
•? Patients at risk from gastrointestinal motility for reasons such as gastrointestinal bleeding, mechanical obstruction, or perforation
•? The presence of a disease causing different results in the evaluation of the digestive system within the past two years
•? Ingestion of drugs that affect the results of the research drug
•? Liver cancer or cirrhosis, chronic renal failure, congestive heart failure
•? Women who are pregnant, lactating, or who are of childbearing age and do not use an appropriate contraceptive method.

发起方